Nayyar Iqbal Selected Research

Neoplasms (Cancer)

1/2019	Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).
10/2014	Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nayyar Iqbal Research Topics

Disease

53	Type 2 Diabetes Mellitus (MODY) 12/2023 - 08/2004
17	Body Weight (Weight, Body) 01/2021 - 04/2009
17	Insulin Resistance 10/2016 - 05/2003
14	Weight Loss (Weight Reduction) 05/2023 - 05/2003
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2004
9	Hypoglycemia (Reactive Hypoglycemia) 08/2018 - 01/2009
8	Atherosclerosis 01/2013 - 05/2003
7	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021 - 08/2004
7	Infections 10/2021 - 02/2013
7	Myocardial Infarction 01/2020 - 02/2014
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 03/2015
6	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021 - 03/2015
6	Stroke (Strokes) 01/2020 - 02/2014
6	Diabetes Mellitus 12/2019 - 02/2009
6	Pancreatitis 08/2019 - 09/2005
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2011 - 05/2003
5	Obesity 05/2023 - 11/2004
5	Heart Failure 11/2019 - 09/2008
5	Urinary Tract Infections (Urinary Tract Infection) 01/2018 - 02/2013
5	Inflammation (Inflammations) 10/2010 - 09/2004
4	Hyperglycemia 11/2016 - 01/2007
4	Morbid Obesity 07/2005 - 05/2003
3	Peripheral Arterial Disease 10/2021 - 02/2010
3	Hypertension (High Blood Pressure) 03/2016 - 01/2007
2	Gangrene 10/2021 - 01/2012
2	Albuminuria 10/2020 - 01/2017
2	Neoplasms (Cancer) 01/2019 - 10/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 09/2014
2	Renal Insufficiency (Renal Failure) 08/2016 - 04/2012
2	Dengue (Dengue Fever) 01/2016 - 04/2012
2	Thrombocytopenia (Thrombopenia) 01/2016 - 10/2014
2	Scrub Typhus (Typhus, Scrub) 01/2016 - 01/2013
2	Headache (Headaches) 01/2015 - 10/2013
2	Pain (Aches) 10/2013 - 04/2012
2	Overweight 05/2010 - 06/2006
2	Thrombosis (Thrombus) 01/2007 - 08/2004
1	Foot Ulcer 10/2021
1	Breast Neoplasms (Breast Cancer) 08/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Unstable Angina 01/2018
1	medullary Thyroid cancer 01/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017
1	Injection Site Reaction 01/2017
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2016

Drug/Important Bio-Agent (IBA)

22	Glucose (Dextrose)FDA LinkGeneric 05/2023 - 04/2009
21	dapagliflozinIBA 12/2023 - 02/2013
19	saxagliptin FDA Link 12/2023 - 10/2013
16	Insulin (Novolin)FDA Link 10/2021 - 11/2004
15	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 11/2010
15	Exenatide (Byetta)FDA Link 10/2020 - 04/2016
7	LipidsIBA 04/2016 - 05/2004
6	CarbohydratesIBA 10/2010 - 05/2003
5	omega-Chloroacetophenone (Mace)IBA 01/2023 - 02/2014
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2020 - 03/2014
5	AdipokinesIBA 01/2013 - 01/2005
4	SuspensionsIBA 10/2020 - 01/2017
4	Glucagon-Like Peptide-1 ReceptorIBA 12/2019 - 04/2016
4	Sodium-Glucose Transport ProteinsIBA 11/2016 - 01/2014
4	Immunoglobulin M (IgM)IBA 01/2016 - 04/2012
4	C-Reactive ProteinIBA 01/2011 - 08/2004
3	SodiumIBA 05/2023 - 03/2017
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 03/2015
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 08/2019 - 01/2017
3	HDL CholesterolIBA 01/2019 - 03/2006
3	Hemoglobins (Hemoglobin)IBA 10/2018 - 07/2011
3	CalciumIBA 02/2011 - 04/2007
3	Triglycerides (Triacylglycerol)IBA 02/2011 - 05/2003
3	Lipoproteins (Lipoprotein)IBA 02/2011 - 09/2004
3	LeptinIBA 10/2010 - 08/2004
3	AdiponectinIBA 10/2010 - 01/2005
2	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2023 - 12/2019
2	IncretinsIBA 08/2019 - 01/2017
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2019 - 01/2017
2	CholesterolIBA 01/2019 - 04/2009
2	LDL CholesterolIBA 01/2019 - 08/2009
2	Hypoglycemic Agents (Hypoglycemics)IBA 08/2016 - 01/2014
2	AntibodiesIBA 01/2016 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 11/2004
2	Glucagon (Glukagon)FDA Link 11/2014 - 08/2014
2	Apolipoproteins B (ApoB)IBA 02/2011 - 08/2009
2	Biomarkers (Surrogate Marker)IBA 10/2010 - 02/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2005 - 11/2004
2	CytokinesIBA 01/2005 - 11/2004
1	glimepiride (Amarel)FDA LinkGeneric 01/2022
1	Hormones (Hormone)IBA 08/2020
1	boldenone undecylenate (Equipoise)IBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2019
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2017
1	Short-Acting InsulinIBA 08/2016

Therapy/Procedure

24	Therapeutics 01/2021 - 03/2006
17	Glycemic Control 05/2023 - 05/2004
6	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 06/2006 - 05/2003
3	Fat-Restricted Diet (Diet, Fat Restricted) 10/2010 - 05/2003
2	Caloric Restriction 05/2023 - 09/2004
2	Surgical Amputation (Amputations) 10/2021 - 12/2019
2	Drug Therapy (Chemotherapy) 08/2020 - 01/2018
1	Diet Therapy (Therapy, Diet) 05/2023
1	Adjuvant Chemotherapy 08/2020
1	Subcutaneous Injections 01/2017